Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEARCH: Antibiotics and Feeding in Severe Pneumonia
NCT04041791Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Aug 2019
- Primary completion
- Apr 2024
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of ceftriaxone, amoxicillin clavulanate in pneumonia, sponsored by University of Oxford. Started Aug 2019; status: completed.
02
Drugs
ceftriaxoneamoxicillin clavulanate
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT04041791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04041791.